S&P 500 Nuclear Giant Vistra Sees 21% Revenue Decline, Narrows 2025 Views

Group 1 - Vistra reported a 21% decline in Q3 revenue to $4.97 billion and a 65% drop in net income to $652 million compared to the previous year [1] - The company narrowed its 2025 guidance following the disappointing earnings report [1] - Despite the negative earnings report, Vistra shares saw a slight increase before the stock market opened [1] Group 2 - Cameco, a top uranium refiner, also reported third-quarter earnings and revenue that fell below analyst expectations [2] - The company is positioned at the forefront of the global nuclear resurgence, indicating potential long-term growth despite current earnings misses [2]